|
|
|
|
|
|
|
Streamlining Testing for Optimized mAb Production
|
Enhance the efficiency of your monoclonal antibody production workflow with end-to-end testing that meets or exceeds regulatory guidelines. This infographic delves into the intricacies of mAb production, emphasizing the importance of accurate and precise testing at various production stages to help ensure product safety, quality, potency, and regulatory compliance. Explore the potential solutions and their benefits, including analysis software, to help de-risk and streamline your production workflow.
|
|
|
|
|
|
|
Debra Miller, CEO and Founder, and Dr. Michael Kelly, Chief Scientific Officer at CureDuchenne talk to Host Erin Harris about the FDA approval for the expansion to the label indication for ELEVIDYS from Sarepta Therapeutics as well as how CureDuchenne works with various biotechs developing gene therapies for Duchenne muscular dystrophy (DMD).
|
|
|
|
|
|
|
|
Clinical Development Of CRISPR-Based Therapies In Oncology
|
|
White Paper | By Matthew Confeld, Ph.D., Jana Knezevic, Ph.D., and Michael F. Murphy, Ph.D., Worldwide Clinical Trials
|
CRISPR-based gene editing techniques provide a way to edit the human genome. Examine the operational implications associated with the evolving therapeutic area of this gene editing tech.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AAV Purification Using AEX And Mixed-Mode Chromatography
|
|
Webinar | Bio-Rad Laboratories, Inc.
|
Recombinant adeno‐associated viruses (rAAV) are among the most promising vectors for long‐term gene transduction. In this study we explore chromatography workflow solutions to purify rAAV8.
|
|
|
|
|
|
Standardization And Flexibility In Aseptic Filling
|
|
Article | Cytiva
|
Standardization and flexibility in aseptic filling were thought to be mutually exclusive. But what if there was a standardized system with flexibility built into the aseptic process, so you didn’t have to choose?
|
|
|
|
|
|
|
|
Better Media, Better Outcomes
|
|
Webinar | Nucleus Biologics
|
As the cell therapy industry experiences rapid growth, media and reagents present a valuable opportunity to meet future therapeutic needs.
|
|
|
|
|
|
Are You Leveraging All Of Your Clinical Data?
|
|
White Paper | Revvity Signals Software, Inc.
|
To develop and execute a successful clinical strategy, trial sponsors must be able to rapidly acquire detailed data insights. See how you can better utilize your trial data and achieve greater insights.
|
|
|
|
|
|
Exploring Electroporation: Immunotherapy
|
|
e-book | MaxCyte, Inc.
|
This collection of articles discusses the development of cancer immunotherapies through cutting-edge genome engineering and sophisticated strategies.
|
|
|
|
|
|
|
|
|
|
|
Don't miss the next Cell & Gene Live discussion on how CAR-T manufacturing has advanced recently and where it's going. Host Tyler Menichiello welcomes CTMC's Jason Bock, Ph.D., Cartesian Therapeutics' Emily English, Ph.D., and former FDA-turned Dark Horse consultant and CMC Expert, Tal Salz, Ph.D., for this digital event happening Tuesday, August 27, at 11 AM ET. Registration is free thanks to the support of CPC.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Webinar: Improve Bioprocess Freezing Outcomes with Analytics and Testing Services
|
Join us on August 26th to learn how reducing early phase inefficiencies can lower initial investments, significantly lower operations costs, and increase productivity. We will share case studies focused on benchmark testing, using surrogate materials, controlled rate freezing, and at line analytics, to identify potential impacts critical to quality, faster and without extensive analytic burden. Click here to learn more.
|
|
|
| Connect With Cell & Gene: |
|
|
|
|
